Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Trevena

NASDAQ TRVN
$0.42 -0.0043 -1.03%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 18 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

5.80M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
-18.19M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
2.41
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
13.96M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-42.43 %

Upcoming events Trevena

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Trevena

Stock analysis Trevena

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-0.20 21.82
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
0.37 5.25
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
0.53 9.04
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.70 0.65
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-827.54 5.86

Price change Trevena per year

1.09$ 3.16$
Min Max

Summary analysis Trevena

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Trevena

Revenue and net income Trevena

All parameters

Stock news Trevena

All news
6 September 2023 в 17:20

Trevena Shares Rise 18% After Getting $15M Tranche

6 September 2023 в 17:20

Trevena Shares Rise 18% After Getting $15M Tranche

10 May 2023 в 19:35

Trevena Shares Drop for Second Day in a Row, Losing 15%

10 May 2023 в 19:35

Trevena Shares Drop for Second Day in a Row, Losing 15%

9 May 2023 в 17:45

Trevena Shares Drop 32% After Big Gains Monday

9 May 2023 в 17:45

Trevena Shares Drop 32% After Big Gains Monday

8 May 2023 в 20:35

Trevena stock soars toward 5-fold gain in very active trading, after pain treatment gets approved in China

8 May 2023 в 17:55

Trevena Shares Triple After Olinvyk Approved as Painkiller in China

8 May 2023 в 17:55

Trevena Shares Triple After Olinvyk Approved as Painkiller in China

8 May 2023 в 14:20

Trevena, Partner Get Approval for Olinvyk in China

8 May 2023 в 14:20

Trevena, Partner Get Approval for Olinvyk in China

16 November 2022 в 16:35

Trevena Shares Slide Premarket on $8 Million Stock Sale >TRVN

16 November 2022 в 16:35

Trevena Shares Slide Premarket on $8 Million Stock Sale >TRVN

28 July 2022 в 14:35

Trevena Sees Positive Topline Results in Olinvyk Trial

28 July 2022 в 14:30

Trevena Sees Positive Topline Results in Olinvyk Trial

10 August 2021 в 00:39

Vanessa Hudgens And Oliver Trevena Backed Caliwater Targets $100 Million Valuation By Catalyzing The Growth Of Cactus Water

About company Trevena

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV027 for the treatment of acute lung injury contributing to acute respiratory distress syndrome and abnormal blood clotting in patients with COVID-19; TRV250, a G protein biased delta-opioid receptor agonist that has completed Phase I clinical study for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR that has completed Phase I clinical study for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. The company has a collaboration with Imperial College London to evaluate Trv027 in Covid-19 patients. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.
Address:
955 Chesterbrook Boulevard, Chesterbrook, PA, United States, 19087
Company name: Trevena
Issuer ticker: TRVN
ISIN: US89532E1091
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2014-01-31
Sector: Healthcare
Industry: Biotechnology
Site: https://www.trevena.com

On which stock exchange are Trevena (TRVN) stocks traded?

Trevena (TRVN) stocks are traded on NASDAQ.

What is the ticker of Trevena stocks (TRVN)?

The stock ticker of Trevena’s stocks or in other words, the code is TRVN. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Trevena (TRVN) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Trevena (TRVN) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Trevena (TRVN) stocks traded?

Trevena (TRVN) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Trevena (TRVN) stocks today?

The current price of Trevena stocks on 12.05.2024 is 0.4157 dollars. per share.

What is the dynamics of Trevena (TRVN) stocks from the beginning of the year?

Trevena (TRVN) quotes have increased by -43.74% from the beginning of the year up to 0.4157 dollars. per 1 stocks.

How much did Trevena (TRVN) stocks increase in мае 2024?

This month Trevena (TRVN) quotes have increased by 8.31% to 0.4157 dollars. per share.

How much are Trevena (TRVN) stocks worth?

Today, on October, 12.05.2024 Trevena’s (TRVN) stocks cost 0.4157 dollars..

What is the market capitalization of Trevena (TRVN)?

Capitalization is the market value of Trevena (TRVN) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 12.05.2024, the market capitalization of Trevena (TRVN) is estimated at about 5804960 dollars.